Rotavirus vaccines: Update on global impact and future priorities

 Abstract

Early rotavirus vaccine adopter countries in the Americas, Europe, and in Australia have documented substantial declines in rotavirus disease burden following the introduction of vaccination.  However, the full public health impact of rotavirus vaccines has not been realized as they have not been introduced into routine immunization programs in countries of Africa and Asia with the highest rotavirus disease morbidity and mortality burden.  In this article, we review the epidemiology of rotavirus disease, the development and current status of rotavirus vaccines including newly available vaccine impact data from early-introducer countries, and future priorities for implementation and monitoring of rotavirus vaccination programs in developing countries.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
1282 - 1290
doi
10.4161/hv.7.12.18321
Type
Review
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Rotavirus vaccines: Update on global impact and future priorities